Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-1995 | 06-1995 | 03-1995 | 12-1994 | 09-1994 | |
| Sales | 2,538,500 | 2,400,700 | 2,337,900 | 2,300,200 | 2,074,900 |
| Cost of Goods | 535,700 | 603,300 | 551,500 | 546,300 | 476,000 |
| Gross Profit | 2,002,800 | 1,878,700 | 1,851,400 | 1,753,900 | 1,598,900 |
| Operating Expenses | 1,312,100 | 1,342,600 | 1,181,900 | 1,251,300 | 1,092,000 |
| Operating Income | 691,400 | 455,100 | 605,000 | 502,900 | 506,900 |
| Interest Expense | 0 | 0 | 49,500 | 30,800 | 32,300 |
| Other Income | -64,600 | 20,400 | 75,400 | 6,800 | 8,200 |
| Pre-tax Income | 626,800 | 475,500 | 630,900 | 478,900 | 482,800 |
| Income Tax | 206,800 | 156,900 | 208,200 | 143,700 | 144,900 |
| Net Income Continuous | 419,100 | 310,900 | 418,600 | 334,000 | 336,500 |
| Net Income Discontinuous | 6,200 | 5,400 | 1,800 | 0 | 0 |
| Net Income | $425,300 | $316,300 | $420,400 | $334,000 | $336,500 |
| EPS Basic Total Ops | 0.11 | 0.08 | 0.11 | 0.09 | 0.09 |
| EPS Basic Continuous Ops | 0.11 | 0.08 | 0.11 | 0.09 | 0.09 |
| EPS Diluted Total Ops | 0.11 | 0.08 | 0.11 | 0.09 | 0.09 |
| EPS Diluted Continuous Ops | 0.11 | 0.08 | 0.11 | 0.09 | 0.09 |
| EBITDA(a) | $691,400 | $455,100 | $605,000 | $502,900 | $506,900 |